How GLP-1 Agonists Work
The Incretin Pathway
GLP-1 Receptor Activation
GLP-1 (Glucagon-Like Peptide-1) is an incretin hormone released from the gut after eating. It enhances insulin secretion, suppresses glucagon, and slows gastric emptying to promote satiety.
Appetite Suppression
GLP-1 agonists activate hypothalamic receptors that reduce hunger and food noise. Users report feeling fuller faster and having less craving for high-calorie foods.
Slowed Gastric Emptying
By delaying stomach emptying, GLP-1 agonists extend the feeling of fullness after meals, reducing overall caloric intake throughout the day.
Beta Cell Preservation
GLP-1 agonists enhance pancreatic beta cell function and may protect against beta cell apoptosis, offering disease-modifying potential in type 2 diabetes.
📋 On this page
Liraglutide
Saxenda / Victoza
The original FDA-approved weight management GLP-1 agonist. Daily injection with proven long-term outcomes.
Daily Injection
Requires daily subcutaneous injection. Some users prefer the routine consistency; others find weekly options more convenient.
LEADER Trial (CV Benefit)
First GLP-1 to demonstrate cardiovascular benefit. 13% reduction in major adverse cardiovascular events (MACE) over 3.8 years.
Dual FDA Approval
Approved for both type 2 diabetes (Victoza, 2010) and chronic weight management (Saxenda, 2014) — the first GLP-1 to achieve both.
SCALE Trial Data
SCALE Obesity & Prediabetes: 8.4% weight loss at 56 weeks. SCALE Maintenance: 6.2% vs placebo 1.8% with lifestyle counseling.
💉 Liraglutide Dosing Schedule (Saxenda)
1 Week 1-2: 0.6mg daily (starting dose)
2 Week 3-4: 1.2mg daily (first escalation)
3 Week 5-6: 1.8mg daily (second escalation)
4 Week 7+: 2.4mg daily (third escalation if tolerated)
5 Max: 3.0mg daily (maintenance dose)
Dulaglutide
Trulicity
Weekly GLP-1 injection using Fc fusion technology for extended half-life. Primarily diabetes-focused with strong CV data.
Fc Fusion Technology
Dulaglutide combines two GLP-1 analog molecules with an Fc fragment, creating a large molecule with a 5-day half-life enabling weekly dosing.
Weekly Convenience
Single weekly injection provides full therapeutic effect. Less injection burden than daily liraglutide, though not approved for weight loss indication.
REWIND Trial (CV Benefit)
12% reduction in MACE cardiovascular events. Notably, REWIND enrolled more patients with lower baseline cardiovascular risk than other GLP-1 CVOTs.
Weight Loss Indication?
Trulicity is NOT approved for weight management — only type 2 diabetes. This is a key distinction vs Saxenda (liraglutide) and Wegovy (semaglutide).
💉 Dulaglutide Dosing Schedule (Trulicity)
1 Week 1-4: 0.75mg weekly (starting dose)
2 Week 5+: 1.5mg weekly (standard maintenance)
3 Higher doses (3mg, 4.5mg) available for enhanced glycemic control
Head-to-Head
GLP-1 Agonist Comparison
Comparing all four major GLP-1 based therapies: Liraglutide, Dulaglutide, Semaglutide, and Tirzepatide.
| Drug | Dosing | Weight Loss | A1C Reduction | CV Benefit | Obesity Approval | Monthly Cost* |
|---|---|---|---|---|---|---|
|
Daily
Liraglutide
|
Daily | ~8% | -1.2% | 13% (LEADER) | ✅ Yes (Saxenda) | $1,000-1,350 |
|
Weekly
Dulaglutide
|
Weekly | ~3-4% | -1.5% | 12% (REWIND) | ❌ No | $850-1,000 |
|
Weekly
Semaglutide
|
Weekly | ~15% | -1.8% | 15% (SELECT) | ✅ Yes (Wegovy) | $1,350-1,700 |
|
New
Tirzepatide
|
Weekly | ~22% | -2.4% | 17% (SURPASS) | ✅ Yes (Zepbound) | $1,000-1,200 |
*WAC pricing — actual cost depends on insurance coverage and formulary tier.
Why Newer GLP-1s Dominate
Why Semaglutide & Tirzepatide Took Over
Superior Efficacy
Tirzepatide (22.5%) dramatically outperforms liraglutide (8%) and dulaglutide (3-4%) in weight loss. Even semaglutide (15%) nearly doubles liraglutide's results.
Better Dosing Convenience
Weekly semaglutide and tirzepatide beat daily liraglutide on convenience. Only one injection weekly vs 7 for daily drugs — dramatically improves adherence.
Oral Option Exists
Semaglutide is available as oral Rybelsus — the only oral GLP-1. No other GLP-1 on this list offers a pill alternative for those with needle aversion.
Latest CV Data
Tirzepatide's SURPASS-CVOT showed 17% CV risk reduction — the strongest cardiovascular outcome of any GLP-1 agonist to date, surpassing LEADER and REWIND.
When to Choose Established GLP-1s
Why Older GLP-1s Are Still Right for Some
These drugs aren't obsolete. For many patients, liraglutide or dulaglutide remain excellent choices based on individual circumstances. The "best" GLP-1 is the one that works for your specific situation.
Insurance & formulary
Older GLP-1s often have better insurance coverage with lower copays. If your formulary prefers liraglutide or dulaglutide, these can be $30-50/month vs $350+ for newer drugs.
Availability
Supply constraints have affected Wegovy and Zepbound. Liraglutide and dulaglutide have more stable supply chains and are more readily available at local pharmacies.
Side Effect Tolerance
Some patients tolerate liraglutide's gradual daily dosing better than weekly high-dose semaglutide. More titratable with smaller dose increments can reduce GI side effects.
Diabetes-Only Indication
For patients with type 2 diabetes who don't need weight loss medication, dulaglutide provides excellent glycemic control without the "weight loss drug" label or costs.
Safety Profile
Side Effects & Warnings
Liraglutide Common Side Effects
Dulaglutide Common Side Effects
Ideal Candidates
Who Should Consider These GLP-1s?
✅ Great Fit For
- Patients with type 2 diabetes seeking glycemic control
- Those with insurance that covers liraglutide/dulaglutide
- Patients experiencing supply issues with semaglutide/tirzepatide
- Those preferring daily routine for consistency
- Patients who tolerate higher-dose weekly GLP-1s poorly
- Anyone needing a gradual titratable approach
⚠️ Consider Other Options
- Patients prioritizing maximum weight loss results
- Those wanting once-weekly dosing convenience
- Patients needing obesity-specific indication
- Those wanting oral medication option (semaglutide)
- Anyone with contraindications to GLP-1 class
References
Key Clinical Trials
🛒 Related Products
Essential supplies for GLP-1 injection protocols
💉 Insulin Syringes 29G
Precision dosing for GLP-1 injections
🧻 Alcohol Swabs
Pre-injection skin preparation
🗑️ Sharps Container
Safe needle disposal container
⚖️ Digital Precision Scale
Track weight loss progress accurately
📏 Body Measuring Tape
Track inches lost beyond scale weight
🩸 Glucose Monitor
Monitor blood sugar during GLP-1 therapy
Affiliate links help support HighPeptides at no extra cost to you.
📚
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
Get the Guide →
⚠️ Medical Disclaimer
This content is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or modifying any medication or supplementation protocol. GLP-1 agonists carry risks including pancreatitis, thyroid tumors, and severe gastrointestinal events. Individual results vary based on diet, exercise, genetics, and other factors.